Outliers in SAR and QSAR: is Unusual Binding Mode a Possible Source of Outliers?

Overview

Journal J Comput Aided Mol Des

Publisher Springer

Specialties Biomedical Engineering
Molecular Biology

Date 2007 Mar 6

PMID 17334823

Citations 10

Authors

Ki Hwan Kim

Affiliations

Soon will be listed here.

Abstract

A lead optimization is usually carried out by structure-activity relationship (SAR) and/or quantitative structure-activity relationship (QSAR) studies. One of the assumptions in SAR and QSAR studies is that similar analogs bind to the same binding site in a similar binding mode. One often observes that there are outliers, especially in QSAR. However, most QSAR studies are carried out focusing their attention to the development of QSAR and leave the outliers without much attention. We searched a number of ligand-bound X-ray crystal structures from the protein structure database to find evidences that could indicate a possible source of outliers in SAR or QSAR. Our results show that unusual binding mode could be a source of outliers.

Citing Articles

Outliers in SAR and QSAR: 4. effects of allosteric protein-ligand interactions on the classical quantitative structure-activity relationships.

Kim K Mol Divers. 2022; 26(6):3057-3092.

PMID: 35192113 DOI: 10.1007/s11030-021-10365-6.

Determination of Ligand Binding Modes in Hydrated Viral Ion Channels to Foster Drug Design and Repositioning.

Zsido B, Borzsei R, Szel V, Hetenyi C J Chem Inf Model. 2021; 61(8):4011-4022.

PMID: 34313421 PMC: 8389532. DOI: 10.1021/acs.jcim.1c00488.

Outliers in SAR and QSAR: 3. Importance of considering the role of water molecules in protein-ligand interactions and quantitative structure-activity relationship studies.

Kim K J Comput Aided Mol Des. 2021; 35(3):371-396.

PMID: 33712973 DOI: 10.1007/s10822-021-00377-7.

How medicinal chemists learned about log P.

Martin Y J Comput Aided Mol Des. 2018; 32(8):809-819.

PMID: 30019206 DOI: 10.1007/s10822-018-0127-9.

Perspective: Alchemical free energy calculations for drug discovery.

Mobley D, Klimovich P J Chem Phys. 2012; 137(23):230901.

PMID: 23267463 PMC: 3537745. DOI: 10.1063/1.4769292.

References

Schweitzer B, Dicker A, Bertino J . Dihydrofolate reductase as a therapeutic target. FASEB J. 1990; 4(8):2441-52. DOI: 10.1096/fasebj.4.8.2185970. View

Musah R, Goodin D . Introduction of novel substrate oxidation into cytochrome c peroxidase by cavity complementation: oxidation of 2-aminothiazole and covalent modification of the enzyme. Biochemistry. 1997; 36(39):11665-74. DOI: 10.1021/bi9708038. View

Gomez G, Morisseau C, Hammock B, Christianson D . Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids. Protein Sci. 2005; 15(1):58-64. PMC: 1762130. DOI: 10.1110/ps.051720206. View

Kester W, Matthews B . Crystallographic study of the binding of dipeptide inhibitors to thermolysin: implications for the mechanism of catalysis. Biochemistry. 1977; 16(11):2506-16. DOI: 10.1021/bi00630a030. View

Bredt D, Snyder S . Nitric oxide, a novel neuronal messenger. Neuron. 1992; 8(1):3-11. DOI: 10.1016/0896-6273(92)90104-l. View

Berman H, Westbrook J, Feng Z, Gilliland G, Bhat T, Weissig H . The Protein Data Bank. Nucleic Acids Res. 1999; 28(1):235-42. PMC: 102472. DOI: 10.1093/nar/28.1.235. View

Holak T, Bode W, Huber R, Otlewski J, Wilusz T . Nuclear magnetic resonance solution and X-ray structures of squash trypsin inhibitor exhibit the same conformation of the proteinase binding loop. J Mol Biol. 1989; 210(3):649-54. DOI: 10.1016/0022-2836(89)90138-1. View

Argiriadi M, Morisseau C, Hammock B, Christianson D . Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase. Proc Natl Acad Sci U S A. 1999; 96(19):10637-42. PMC: 17935. DOI: 10.1073/pnas.96.19.10637. View

Grant R, Hiremath C, Filman D, Syed R, Andries K, Hogle J . Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr Biol. 1994; 4(9):784-97. DOI: 10.1016/s0960-9822(00)00176-7. View

10.

Hadfield A, Oliveira M, Kim K, Minor I, Kremer M, Heinz B . Structural studies on human rhinovirus 14 drug-resistant compensation mutants. J Mol Biol. 1995; 253(1):61-73. DOI: 10.1006/jmbi.1995.0536. View

11.

Braun W, Vasak M, Robbins A, Stout C, Wagner G, KAGI J . Comparison of the NMR solution structure and the x-ray crystal structure of rat metallothionein-2. Proc Natl Acad Sci U S A. 1992; 89(21):10124-8. PMC: 50290. DOI: 10.1073/pnas.89.21.10124. View

12.

Argiriadi M, Morisseau C, Goodrow M, Dowdy D, Hammock B, Christianson D . Binding of alkylurea inhibitors to epoxide hydrolase implicates active site tyrosines in substrate activation. J Biol Chem. 2000; 275(20):15265-70. DOI: 10.1074/jbc.M000278200. View

13.

Whitlow M, Howard A, Stewart D, HARDMAN K, Chan J, Baccanari D . X-Ray crystal structures of Candida albicans dihydrofolate reductase: high resolution ternary complexes in which the dihydronicotinamide moiety of NADPH is displaced by an inhibitor. J Med Chem. 2001; 44(18):2928-32. DOI: 10.1021/jm0101444. View

14.

Kim C, Chandra P, Jain A, Christianson D . Fluoroaromatic-fluoroaromatic interactions between inhibitors bound in the crystal lattice of human carbonic anhydrase II. J Am Chem Soc. 2001; 123(39):9620-7. DOI: 10.1021/ja011034p. View

15.

Chung S, Kim D . N-(Hydroxyaminocarbonyl)phenylalanine: a novel class of inhibitor for carboxypeptidase A. Bioorg Med Chem. 2001; 9(1):185-9. DOI: 10.1016/s0968-0896(00)00235-2. View

16.

Teplyakov A, Wilson K, Orioli P, Mangani S . High-resolution structure of the complex between carboxypeptidase A and L-phenyl lactate. Acta Crystallogr D Biol Crystallogr. 1993; 49(Pt 6):534-40. DOI: 10.1107/S0907444993007267. View

17.

Orville A, Lipscomb J, Ohlendorf D . Crystal structures of substrate and substrate analog complexes of protocatechuate 3,4-dioxygenase: endogenous Fe3+ ligand displacement in response to substrate binding. Biochemistry. 1997; 36(33):10052-66. DOI: 10.1021/bi970469f. View

18.

Lindskog S . Structure and mechanism of carbonic anhydrase. Pharmacol Ther. 1997; 74(1):1-20. DOI: 10.1016/s0163-7258(96)00198-2. View

19.

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

20.

Musah R, Jensen G, Bunte S, Rosenfeld R, Goodin D . Artificial protein cavities as specific ligand-binding templates: characterization of an engineered heterocyclic cation-binding site that preserves the evolved specificity of the parent protein. J Mol Biol. 2002; 315(4):845-57. DOI: 10.1006/jmbi.2001.5287. View